Doctorate fady zakaria: Newgiza University, Egypt

Fady Zakaria is a dedicated medical student in his second year at Newgiza University, specializing in pediatric neurology with a particular interest in epilepsy. Fady’s academic journey is driven by a deep passion for exploring molecular biology and its applications in the diagnosis and treatment of neurological conditions. As an aspiring physician-scientist, his research aims to bridge the gap between molecular mechanisms and clinical practices, particularly in pediatric populations. His work is characterized by a meticulous approach to scientific inquiry, a strong desire to contribute to medical knowledge, and a commitment to improving pediatric healthcare outcomes.

Online Profiles

ORCID Profile

At this stage, Fady does not have a personal website or LinkedIn profile. However, his professional identity and research contributions can be accessed through his academic affiliations and publications, which highlight his ongoing dedication to advancing medical research. He is actively working towards developing an online presence that will reflect his growing body of research and professional experiences as he progresses through his medical career.

Education

Fady Zakaria is currently enrolled in the undergraduate medical program at Newgiza University, where he has been excelling in both clinical and research components of his education. His academic journey is set to culminate in his graduation with a Bachelor of Medicine, Bachelor of Surgery (MBBCH) degree in March 2024. Throughout his medical education, Fady has demonstrated a particular interest in neurobiology and molecular genetics, specifically as they relate to pediatric epilepsy. His studies have provided him with a strong foundation in both theoretical and practical aspects of medicine, preparing him for future research and clinical practice in neurology.

Research Focus

Fady’s current research is centered around the role of microRNAs (miRNAs) in pediatric epilepsy, focusing on their potential as both biomarkers for early diagnosis and therapeutic targets for treatment. His work investigates the molecular pathways through which miRNAs influence neuronal function and how they can be harnessed to improve clinical outcomes for children suffering from epilepsy. By identifying specific miRNA profiles associated with epilepsy, Fady aims to contribute to a deeper understanding of the disease’s pathogenesis and to propose novel, non-invasive diagnostic tools. His research is driven by a desire to address the unmet needs of pediatric patients who face chronic neurological disorders.

Experience

Although Fady is early in his research career, he has already gained invaluable experience through active participation in several research projects and clinical audits. As a first author, he presented a study on the role of venous thromboembolism prophylaxis in general surgical patients at the Annual Meeting of Al-Salam Surgeons in May 2025, which gave him an opportunity to engage with professionals in the surgical and clinical fields. Additionally, Fady contributed to the preparation of a presentation on “Closing defects, from simple to difficult” at the United Conference of Hepatogastroenterology and Infectious Diseases in 2024. This exposure to a wide range of medical disciplines has provided him with the practical skills and interdisciplinary knowledge necessary to tackle complex clinical questions. Fady continues to refine his skills in both research and presentation, positioning himself for a future in academic medicine.

Research Timeline

• 2023-Present: Fady’s research journey began in 2023, when he started investigating the role of miRNAs in pediatric epilepsy as part of his academic focus at Newgiza University. This research is ongoing and is expected to culminate in further publications and potential collaborations with experts in neurology and genetics.

• 2024: As part of his final year of medical school, Fady plans to expand his research into therapeutic applications of miRNA-based treatments for pediatric epilepsy. This year will also mark the completion of his undergraduate medical education and the beginning of his transition into more specialized clinical and research roles.

• 2025 and Beyond: After graduation, Fady intends to pursue a medical career that combines clinical practice with continued research in molecular neurology, aiming to contribute to the development of personalized treatment plans for children with epilepsy.

Awards & Honors

Though Fady has not yet received formal awards or honors, his contributions to the field are already gaining attention. His work was recognized during the Annual Meeting of Al-Salam Surgeons in 2025, where he presented his clinical audit on thromboembolism prevention. This recognition is just the beginning of what is expected to be a promising academic and clinical career. Fady continues to work diligently on his research and aims to earn accolades as his contributions to the field expand.

Top-Noted Publication

Fady’s most notable publication to date is the systematic review titled The Role of MicroRNAs in the Pathogenesis and as Biomarkers for Pediatric Epilepsy, published in Molecular Diagnosis & Therapy on June 8, 2025. The publication, co-authored with prominent experts in the field, delves into the potential of miRNAs to not only serve as biomarkers for early diagnosis of epilepsy in children but also to guide the development of novel therapeutic strategies. This work is a significant contribution to the field, offering a comprehensive review of the existing literature while proposing new avenues for future research. Fady’s ability to synthesize complex data and present it clearly has earned him recognition among his peers and mentors.

Fady Zakaria’s most notable publication is the journal article The Role of MicroRNAs in the Pathogenesis and as Biomarkers for Pediatric Epilepsy: A Systematic Review, published in Molecular Diagnosis & Therapy on June 8, 2025. This article delves into the potential of microRNAs (miRNAs) as both biomarkers for early diagnosis and therapeutic targets in pediatric epilepsy. The systematic review synthesizes current research on the molecular mechanisms underlying epilepsy and discusses how miRNAs could revolutionize diagnostic practices and treatment strategies for children with this neurological condition. Fady co-authored this paper alongside Steven Amged Yousef, Janna AbdelDayem, Rawan ElGamal, Omar Y. Issa, Mohamed Mansour, Harvey Bastorous, Eslam Emad, and Rudayna Mahgoub. The paper has garnered attention for its in-depth analysis and forward-looking approach to the role of miRNAs in epilepsy.

DOI: 10.1007/s40291-025-00791-9